Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07221643 · ClinicalTrials.gov registry record
Carotenoids in the Skin and Immune Aging
A clinical trial of No Condition and Skin Carotenoids and Immune-aging, sponsored by Stanford University.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT07221643: Recruiting study of No Condition and Skin Carotenoids and Immune-aging, sponsored by Stanford University.
NCT07221643 is a study of No Condition and Skin Carotenoids and Immune-aging that is actively recruiting participants, run by Stanford University. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07221643, a study of No Condition and Skin Carotenoids and Immune-aging, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to examine the connection between the level of carotenoids in the skin and a number of immune related health parameters.
Primary Outcome
We will assess the skin carotenoid levels' correlation with skin aging features, such as wrinkles, fine lines, and age spots.
Conditions Studied
Study Locations (1)
California
- Stanford Health - General Dermatology Clinic - Redwood City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-10-09 |
| Est. Completion | 2026-04-01 |
What NCT07221643 shows while recruiting
NCT07221643 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 2 conditions, with No Condition appearing as the primary indexed condition, and to 0 interventions.
NCT07221643 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07221643 about?
NCT07221643 is a clinical study titled "Carotenoids in the Skin and Immune Aging". This study aims to examine the connection between the level of carotenoids in the skin and a number of immune related health parameters.
What is the current status of trial NCT07221643?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2025-10-09. Estimated completion is 2026-04-01.
What conditions does trial NCT07221643 study?
This clinical trial studies the following conditions: No Condition, Skin Carotenoids and Immune-aging.
Who is sponsoring clinical trial NCT07221643?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07221643 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for No Condition
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI